Live Breaking News & Updates on Biomed Media Contact

Stay updated with breaking news from Biomed media contact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe

Company s Liver Cancer Drug Candidate IP Portfolio strengthened
Company provides operational update on strategic opportunities
NEW YORK, April 14, 2023 /PRNewswire/ Q BioMed Inc. a biotech. | April 14, 2023 ....

United States , Keith Pinder , Denis Corin , Cq Biomed Inc , Oklahoma Medical Research Foundation , Sourceq Biomed Inc , Qbiomed Inc , Department Of Biotechnology , Securities Exchange , Mannin Research , Rajiv Gandhi Centre For Biotechnology , Autonomous Institute , America Cancer Society , Company Liver Cancer Drug , Liver Cancer Drug Candidate , Liver Cancer Market , Orphan Drug , Rajiv Gandhi Centre , Oklahoma Medical Research , Abiomed Inc , Looking Statements , Securities Act , Securities Exchange Act , Biomed Media Contact , Q Biomed Inc Stock Exchange , Press Release ,

Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office

/PRNewswire/ Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical. ....

United States , Q Biomed Uttroside , Denis Corin , Keith Pinder , America Cancer Society , Cq Biomed Inc , Sourceq Biomed Inc , Department Of Biotechnology , Rajiv Gandhi Centre For Biotechnology , Oklahoma Medical Research Foundation , Autonomous Institute , Securities Exchange , Uttrosideb Has Shown Promising Results , Initial Pre Clinical , Liver Cancer , Orphan Drug , Orphan Drug Status , Derivatives Thereof , Hepatocellular Carcinoma , Rajiv Gandhi Centre , Oklahoma Medical Research , Biomed Media Contact , Relations Contact , Looking Statements , Securities Act , Securities Exchange Act ,

Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.

/PRNewswire/ Q BioMed Inc. (QBIO), a commercial stage biotechnology acceleration development company, is pleased to announce that it has converted its. ....

Georgen Nikopoulos , Susan Quaggin , Denis Corin , Keith Pinder , Prnewswireq Biomed Inc , Securities Exchange , Cq Biomed Inc , Sourceq Biomed Inc , Mannin Research Inc , Mannin Research , Research Inc , Looking Statements , Securities Act , Securities Exchange Act , Biomed Media Contact , Cq Biomed Inc ,

Traders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc.

NEW YORK, NY / ACCESSWIRE / August 25, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued ....

South Africa , Kostenloser Wertpapierhandel , Paul Lipp , Mark Roberts , Denis Corin , Denisd Corin , Keith Pinder , Traders News Source , Cq Biomed Inc , Tapimmune Inc , University Of Natal , Chairmanq Biomed , News Source , Chief Executive Officer , Management Consultant , Bachelors Degree , Advertising Management , News Source Editor Mark Roberts , Abiomed Inc , Biomed Media Contact , Call Paul Lipp ,

Q BioMed Inc. Provides Update to Shareholders

/PRNewswire/ Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical. ....

Denis Corin , Keith Pinder , Partnership Or Collaboration Opportunities , Company Reports Revenue Improvement , Securities Exchange , Cq Biomed Inc , Sourceq Biomed Inc , Drug Platform Development , Positive Data , Liver Cancer , Orphan Drug Designation , Abiomed Inc , Looking Statements , Securities Act , Securities Exchange Act , Biomed Media Contact ,